09.12.2012 Views

NAMS 2002 Workshop - ICOM 2008

NAMS 2002 Workshop - ICOM 2008

NAMS 2002 Workshop - ICOM 2008

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Biomedical and Biotechnology I – 4<br />

Monday July 14, 11:15 AM-11:45 AM, Honolulu/Kahuku<br />

Separation and Purification of Hematopoietic Stem Cells from Human<br />

Blood through Surface-modified Membranes<br />

A. Higuchi (Speaker), Nat. Central Univ. & Nat. Res. Institute for Child Health & Develop., Tokyo,<br />

Japan, higuchi@ncu.edu.tw<br />

Y. Chang, Chung Yuan Christian University, Taoyuan, Taiwan<br />

R. Ruaan, National Central University, Taoyuan, Taiwan<br />

W. Chen, National Central University, Taoyuan, Taiwan<br />

Efficient cell separation is important for the successful isolation and purification of<br />

blood cells, stem cells and specific tissue cells. Techniques such as<br />

centrifugation, affinity column chromatography, and fluorescence activated cell<br />

sorting (FACS), magnetic cell selection, and membrane filtration are typically<br />

employed for cell separation. The centrifugal separation of cells is a typical<br />

method employed to isolate platelets, leukocytes, mononuclear cells, red blood<br />

cells and non-blood cells. Highly purified cellular preparations are obtained using<br />

FACS or a magnetic cell selection system in conjunction with a fluorescentlylabeled<br />

antibody as the cell-surface marker. Cell separation through membrane<br />

filtration was recently reported by several researchers. Leukocyte removal filters<br />

are commercially available cell separation filters. The stem cells that form blood<br />

and immune cells are known as hematopoietic stem cells. Hematopoietic stem<br />

and progenitor cells bear the CD34 cell surface marker. These cells are thought<br />

to be responsible for the reconstitution of hematopoiesis. Therefore, the<br />

transplantation of CD34+ cells is essential in the therapy of patients with acute<br />

myeloid leukemia, myelodysplastic syndromes, chronic myeloid leukemia and<br />

systemic mastocytosis. In a previous investigation (A. Higuchi et al., J. Biomed.<br />

Mater. Res. 68A, 34 (2004)), cell separation from peripheral blood at fixed blood<br />

permeation speeds (1 ml/min) was investigated using surface-modified<br />

polyurethane (PU) membranes with a fixed pore size of 5 mm, carrying different<br />

functional groups. However, optimal conditions for the purification of CD34+ cells<br />

from blood using membrane filtration were still undetermined. In this study, we<br />

prepared several of the membranes, and conducted further experiments on the<br />

separation of CD34+ cells using the membranes.<br />

Cell separation from peripheral blood was investigated using polyurethane (PU)<br />

foam membranes having 5.2 mm pore size and coated with Pluronic F127 or<br />

hyaluronic acid. The permeation ratio of hematopoietic stem cells (CD34+ cells)<br />

and lymphocytes through the membranes was lower than for red blood cells and<br />

platelets. Adhered cells were detached from membrane surfaces using human<br />

serum albumin solution after permeation of blood through the membranes,<br />

allowing isolation of CD34+ cells in the permeate (recovery) solution. High- yield

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!